Thomas Talbot
- Dermatology top 1%
- Dermatology and Skin Diseases 6
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Structural Biology top 5%
- Rehabilitation top 5%
- Wound Healing and Treatments 5
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 4
-
- Cancer Immunotherapy and Biomarkers 8
-
- Helicobacter pylori-related gastroenterology studies 4
-
- Cardiac Imaging and Diagnostics 3
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Nora V. BergasaStephen E. EpsteinDavid W. AllingE. Anthony JonesJoseph M. SchmittElijah C. WalkerMaria L. TurnerM.G. Swain
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (2 papers)The Journal of the Acoustical Society of America (2 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Thomas Talbot
44 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Dermatology 368
- Hepatology 314
- Structural Biology 43
- Rehabilitation 138
- Pharmacology 159
Countries citing papers authored by Thomas Talbot
This map shows the geographic impact of Thomas Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Talbot more than expected).
Fields of papers citing papers by Thomas Talbot
This network shows the impact of papers produced by Thomas Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Talbot. The network helps show where Thomas Talbot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Talbot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 11 | |
| 6 | First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743breakdown → | 2022 | 158 |
| 7 | 2021 | 8 | |
| 8 | 2021 | 31 | |
| 9 | 2017 | 27 | |
| 10 | 2006 | 16 | |
| 11 | 2005 | 3 | |
| 12 | 2004 | 57 | |
| 13 | 2001 | 6 | |
| 14 | 1999 | 110 | |
| 15 | 1993 | 42 | |
| 16 | 1992 | 212 | |
| 17 | 1991 | 77 | |
| 18 | 1991 | 69 | |
| 19 | 1991 | 23 | |
| 20 | 1954 | 36 |
About Thomas Talbot
Thomas Talbot is a scholar working on Structural Biology, Dermatology and Hepatology, having authored 45 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Dermatology and Skin Diseases (6 papers), Wound Healing and Treatments (5 papers), Pharmacological Effects of Natural Compounds (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Cardiac Imaging and Diagnostics (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Dermatology (368 citations), Hepatology (314 citations) and Structural Biology (43 citations). Thomas Talbot has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Nora V. Bergasa, Stephen E. Epstein, David W. Alling, E. Anthony Jones, Joseph M. Schmitt, Elijah C. Walker, Maria L. Turner, M.G. Swain, Cihan Yurdaydın and GARY D. SALOMON. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of the Acoustical Society of America, Microscopy and Microanalysis and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.